155
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Molecular characterization of Staphylococcus aureus isolates derived from severe pneumonia: a retrospective monocentre study

, , &
Pages 811-819 | Received 03 May 2021, Accepted 28 Jul 2021, Published online: 12 Aug 2021

References

  • Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–532.
  • Grumann D, Nübel U, Bröker BM. Staphylococcus aureus toxins-Their functions and genetics. Infect Genet Evol. 2014;21:593–592.
  • Berube BJ, Bubeck Wardenburg J. Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel)). 2013;5(6):1140–1166.
  • Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury . Proc Natl Acad Sci U S A. 2010;107(12):5587–5592.
  • Bloes DA, Haasbach E, Hartmayer C, et al. Phenol-soluble modulin peptides contribute to influenza a virus-associated Staphylococcus aureus pneumonia. Infect Immun. 2017;85:e0062017.
  • Foster TJ. The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2016;35(12):1923–1931.
  • Löffler B, Niemann S, Ehrhardt C, et al. Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection. Expert Rev anti Infect Ther. 2013;11(10):1041–1051.
  • Roux S, Vandenesch F, Perpoint T, et al. Necrotising pneumonia following influenza due to PVL-negative Staphylococcus aureus in a 64-year-old woman. BMJ Case Rep. 2017;2017:bcr2017222542.
  • Mushtaq F, Hildrew S, Okugbeni G, et al. Necrotizing haemorrhagic pneumonia proves fatal in an immunocompetent child due to Panton-Valentine leucocidin, toxic shock syndrome toxins 1 and 2 and enterotoxin C-producing Staphylococcus aureus. Acta Paediatr. 2008;97(7):985–987.
  • Li Z, Stevens DL, Hamilton SM, et al. Fatal S. aureus hemorrhagic pneumonia: genetic analysis of a unique clinical isolate producing both PVL and TSST-1. Plos One. 2011;6(11):e27246.
  • Azuma K, Koike K, Kobayashi T, et al. Detection of circulating superantigens in an intensive care unit population. Int J Infect Dis. 2004;8(5):292–298.
  • Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250.
  • Lim WQ, van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
  • Monecke S, Slickers P, Ehricht R. Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol. 2008;53(2):237–251.
  • Monecke S, Coombs G, Shore AC, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. Plos One. 2011;6(4):e17936.
  • Haider S, Wright D. Panton-Valentine leukocidin Staphylococcus causing fatal necrotising pneumonia in a young boy. BMJ Case Rep. 2013;2013:bcr2012007655.
  • Lemaître C, Angoulvant F, Gabor F, et al. Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a french tertiary care center. Pediatr Infect Dis J. 2013;32(10):1146–1149.
  • Patterson CM, Loebinger MR. Community acquired pneumonia: assessment and treatment. Clin Med (Lond)). 2012;12(3):283–286.
  • Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcome of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854–3862.
  • Garbacz K, Piechowicz L, Podkowik M, et al. Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients. Infect Drug Resist. 2018;11:247–255.
  • Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35(7):819–824.
  • Gillet Y, Dumitrescu O, Tristan A, et al. Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases. Int J Antimicrob Agents. 2011;38(6):457–464.
  • Khanafer N, Sicot N, Vanhems P, et al. Severe leukopenia in Staphylococcus aureus necrotizing, community-acquired pneumonia: risk factors and impact on survival. BMC Infect Dis. 2013;13(1):359.
  • Fischer AJ, Kilgore SH, Singh SB, et al. High prevalence of Staphylococcus aureus enterotoxin gene cluster superantigens in cystic fibrosis clinical isolates. Genes. 2019;10:1036.
  • Becker K, Friedrich AW, Lubritz G, et al. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol. 2003;41(4):1434–1439.
  • van Belkum A, Melles DC, Snijders SV, et al. Clonal distribution and differential occurrence of the enterotoxin gene cluster, egc, in carriage- versus bacteremia-associated isolates of Staphylococcus aureus. J Clin Microbiol. 2006;44(4):1555–1557.
  • Ferry T, Thomas D, Genestier AL, et al. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis. 2005;41(6):771–777.
  • Robinson DA, Kearns AM, Holmes A, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet. 2005;365(9466):1256–1258.
  • Schweizer ML, Furuno JP, Sakoulas G, et al. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob Agents Chemother. 2011;55(3):1082–1087.
  • He C, Xu S, Zhao H, et al. Leukotoxin and pyrogenic toxin superantigen gene backgrounds in bloodstream and wound Staphylococcus aureus isolates from Eastern region of China. BMC Infect Dis. 2018;18:395.
  • Blomfeldt A, Aamot HV, Eskesen AN, et al. Molecular characterization of methicillin-sensitive Staphylococcus aureus isolates from bacteremic patients in a norwegian university hospital. J Clin Microbiol. 2013;51(1):345–347.
  • Jarraud S, Mougel C, Thioulouse J, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002;70(2):631–634.
  • Lindsay JA, Moore CE, Day NP, et al. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol. 2006;188(2):669–676.
  • Alfouzan W, Udo EE, Modhaffer A, et al. Molecular characterization of Methicillin- Resistant Staphylococcus aureus in a Tertiary Care hospital in Kuwait . Sci Rep. 2019;9(1):18527.
  • Ruimy R, Maiga A, Armand-Lefevre L, et al. The carriage population of Staphylococcus aureus from Mali is composed of a combination of pandemic clones and the divergent Panton-Valentine leukocidin-positive genotype ST152. J Bacteriol. 2008;190(11):3962–3968.
  • Stegger M, Wirth T, Andersen PS, et al. Origin and evolution of european methicillin-resistant Staphylococcus aureus. mBio. 2014;5:01044–01014.
  • Dauwalder O, Lina G, Durand G, et al. Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007. J Clin Microbiol. 2008;46(10):3454–3458.
  • Deasy EC, Brennan GI, Tecklenborg SC, et al. A molecular epidemiological investigation of methicillin-susceptible Staphylococcus aureus causing bloodstream infections in Ireland, 2006-2017. Eur J Clin Microbiol Infect Dis. 2019;38(5):927–936.
  • Roe CH, Stegger M, Lilje B, et al. Genomic analyses of Staphylococcus aureus clonal complex 45 isolates does not distinguish nasal carriage from bacteraemia. Microb Genom. 2020;6:mgen000403.
  • Holden MTG, Feil EJ, Lindsay JA, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA. 2004;101(26):9786–9791.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.